IP Library Granted Patent US 7,901,713
Granted Patent B2
US 7,901,713 · App. 10/866,315 · Granted Mar 8, 2011

Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,901,713
App. No.
10/866,315
Granted
Mar 8, 2011
Kind
B2
Abstract

A natural formulation of compounds isolated or derived from hops which inhibit the activity of cyclooxygenase-2 (COX-2) and/or 5-lipoxygenase (5-LOX) is disclosed. The hops formulations may be administered to a mammal to treat or inhibit a pathological condition associated with the activity of COX-2 and/or 5-LOX in such a mammal.

Claims (15)

1. A method of treating an inflammatory condition in a mammal in need thereof, the method comprising administering to the mammal in need thereof a composition comprising a therapeutically effective amount of a compound selected from the group consisting of dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone, hexahydro-isocohumulone and hexahydro-isoadhumulone.

2. The method of claim 1 , wherein the compound is derived from hops.

3. The method of claim 1 , wherein the inflammatory condition is cancer.

4. The method of claim 3 , wherein the cancer is breast cancer.

5. The method of claim 3 , wherein the cancer is prostate cancer.

6. The method of claim 3 , wherein the cancer is colon cancer.

7. The method of claim 3 , wherein the cancer is pancreatic cancer.

8. The method of claim 1 , wherein the inflammatory condition is asthma.

9. The method of claim 1 , wherein the inflammatory condition is Alzheimer's Disease.

10. The method of claim 1 , wherein the inflammatory condition is arthritis.

11. The method of claim 1 , wherein the inflammatory condition is Crohn's Disease.

12. The method of claim 1 , wherein the inflammatory condition is eczema.

13. The method of claim 1 , wherein the inflammatory condition is Inflammatory Bowel Disease.

14. The method of claim 1 , wherein the inflammatory condition is osteoarthritis.

15. The method of claim 1 , wherein the inflammatory condition is psoriasis.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2021
From: BANK OF AMERICA, N.A.
To: META PROTEOMICS, LLC
Reel/Frame 057909/0199 →
RELEASE OF SECURITY INTEREST Recorded Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023424/0038 →
SECURITY AGREEMENT Recorded Oct 15, 2009
From: META PROTEOMICS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 023373/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2008
From: TRIPP, MATTHEW L.; DARLAND, GARY K.; FULLER, MARK; BABISH, JOHN G.; BLAND, JEFFREY S.
To: METAPROTEOMICS, LLC
Reel/Frame 021748/0663 →
SECURITY AGREEMENT Recorded Jun 2, 2006
From: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, L.L.C.
To: COMERICA BANK
Reel/Frame 017706/0815 →